Distribution of autologous bone marrow stromal cell derived stem cells in damaged and other brain regions
Yi-wu Dai,Ru-xiang Xu,Chun-ping Zhao
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.45.015
2006-01-01
Abstract:BACKGROUND: In recent years, the discovery that bone marrow stromal cells (BMSCs) have the potential of multi-differentiation, especially the successful differentiation of BMSCs to neural stem cells (NSCs), has provided possibility for cell transplantation in treating injury of nervous system. OBJECTIVE: To observe the therapeutic effect of the aurotransplantation of BMSCs-derived stem cells on brain injury. DESIGN: A prospective study by taking the distribution of BrdU labeled autologous BMSCs-derived stem cells in the damaged and other brain areas of animal models as the observational object. MATERIALS: The experiments were carried out in the General Hospital of Beijing Military Area Command of Chinese PLA from October 1999 to February 2002. Twenty-two adult dogs of 1.5-3.0 years old, either males or females, weighing (13±2) kg, were randomly divided into sham-operated group (n=6), routine treatment group (n=8) and BMSCs-derived stem cells group (n=8). METHODS: Dog BMSCs were collected proliferated, separated, pre-differentiated in vitro, marked and cultured. In the sham-operated group, the dogs were only treated with skin incision and skull drilling, but not induced to midbrain injury, and they could eat normally after became conscious from anesthesia. After lesion of midbrain tagmental area, in the routine treatment group, adenosine triphosphate (20 mg) and coenzyme A (50 u) were added to salineand then dripped via vein, twice a day for 3 days; In the BMSCs-derived NSCs group, the mixture of 1 mL BMSCs-derived NSCs and 1 mL cerebrospinal fluid was infused into the brain ventricle, once a day for 3 days continuously. The distribution of BMSCs-derived stem cells in the damaged and other brain areas was observed on the 1st, 7th, 14th and 28th days postoperatively. MAIN OUTCOME MEASURES: The distribution of BMSCs-derived stem cells in the damaged and other brain areas was observed. RESULTS: All the 22 dogs were involved in the analysis of results. ① On the 28th day postoperatively, the number of BrdU positive cells in the BMSCs-derived NSCs group was obviously higher than those in the sham-operated group and routine treatment group (15.4±2.4), (0.5±0.5), (0.5±0.5) cells. ② On the 14th day postoperatively in the BMSCs-derived NSCs group, the number of BrdU positive cells in ipsilateral midbrain was obviously higher than that in the contralateral one (15.5±3.3), (5.0±1.5) cells, and that in the ipsilateral frontal lobe was higher than that in the contralateral one (1.6±0.6), (1.5±0.7) cells. CONCLUSION: The number of BrdU positive cells in the damaged area of the BMSCs-derived NSCs group was obviously more than that in the contralateral areas and those in the same sites of the other two groups, it is indicated that BMSCs-derived stem cells can immigrate to the damaged brain area, and they can accelerate the recovery of brain stem injuries.